A biochip-based combined immunoassay for detection of serological status of Borrelia burgdorferi in Lyme borreliosis

The combined biochip-based immunoassay, as a potential substitution of ELISA, provided a promising approach to extend the detection spectrum of infectious antibodies against a panel of Borrelia antigens.